目的:由于不明原因的体外受精失败经常发生,确定潜在的潜在预测因子具有重要的临床价值.这项研究旨在探讨具有小顶体的精子百分比是否与无法解释的体外受精失败有关。
方法:将一种新的顶体功能评估指标(具有小顶体的精子百分比)引入精子形态分析中。通过顶体酶活性检测试验和顶体反应试验研究了该指标与顶体功能之间的关系。此外,进一步探讨了与原因不明的体外受精失败的相关性。最后,用ROC曲线分析体外受精失败的诊断效能,并计算临界值。
结果:随着具有小顶体的精子百分比的增加,顶体酶活性的价值,顶体反应速率,体外受精率降低,差异具有统计学意义(P<0.05)。低受精率组各项指标明显高于正常受精率组(P<0.05)。最后,ROC曲线的结果发现,当指数为43.5%时,敏感性和特异性分别为74.2%和95.3%,分别。
结论:顶体小的精子百分比与无法解释的体外受精失败呈正相关,这可能被用作体外受精失败的预后指标。
背景:[伦理审查接受号IIT20210339B]。
OBJECTIVE: Since the unexplained in vitro fertilization failure occurs frequently, it is of great importance and clinical value to identify potential underlying predictors. This study aimed to explore whether the percentage of sperm with a small acrosome was correlated with unexplained in vitro fertilization failure.
METHODS: A new acrosomal function evaluation index (the percentage of sperm with a small acrosome) was introduced into the analysis of sperm morphology. The association between the index and acrosome function by acrosin activity detection test and acrosome reaction test was investigated. In addition, the correlation with unexplained in vitro fertilization failure was further explored. Finally, the ROC curve was used to analyze the diagnostic efficacy on the failure of in vitro fertilization and the cutoff value was calculated.
RESULTS: As the increasing of the percentage of sperm with a small acrosome, the value of acrosin activity, acrosome reaction rate, and in vitro fertilization rate were reduced, with a statistically significant difference (P < 0.05). The index in the low fertilization rate group was significantly higher than that in the normal fertilization rate group (P < 0.05). Finally, the results of ROC curve found that when the index was 43.5%, the sensitivity and specificity were 74.2% and 95.3%, respectively.
CONCLUSIONS: The percentage of sperm with a small acrosome was positively correlated with unexplained in vitro fertilization failure, which could be potentially used as a prognostic index for the failure of in vitro fertilization.
BACKGROUND: [Ethics review acceptance No IIT20210339B].